Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Date

Cohance Lifesciences Board Meeting Date

Cohance Lifesciences Ltd has scheduled a Board Meeting on May 12, 2026, to approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company's trading window remains closed until May 14, 2026.

Source

BSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cohance Lifesciences Ltd: key numbers

Share price
₹476.05
Market cap
₹18,214 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
171.4×Sector 46.1×
Promoter holding
57.48%-0.01% QoQ
FII holding
7.71%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cohance Lifesciences Ltd

All →

Other board meeting date announcements

All →